4D Molecular Therapeutics, Inc. ( FDMT) - Key Metrics
FDMT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.47 | $0.33 | $0.49 | $0.48 |
| 2025Q3 | $0 | -$1.01 | -$0.83 | -$0.83 |
| 2025Q2 | $0 | -$0.98 | -$0.78 | -$0.78 |
| 2025Q1 | $0 | -$0.86 | -$0.86 | -$0.87 |
FDMT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 5.60 |
| 2025Q3 | ? | -2.14 |
| 2025Q2 | ? | -0.95 |
| 2025Q1 | ? | -0.94 |
FDMT
Price: $10.07
52 week price:
Earnings Per Share: -2.57 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 192795
Market Capitalization: 679.6 million